Why United States Antimony is back on investor radars

United States Antimony (UAMY) is drawing fresh attention after scheduling its Q2 2026 earnings release for after the market close on August 11, along with a Bloomberg Television appearance by Chairman and CEO Gary C. Evans.

These updates arrive as the stock has recently recorded gains linked to higher antimony demand and improving sentiment toward rare earth related materials. This has put the company in focus for investors watching industrial and environmental applications.

United States Antimony’s share price has been volatile, with a 7 day share price return of 17.84% and a 90 day share price decline of 36.48%, while the 3 year total shareholder return is very large. This mix of recent weakness and longer term gains sets the backdrop for the upcoming Q2 earnings update and Bloomberg appearance. Many investors see these events as potential catalysts that could shift expectations around growth prospects and risk.

If you are tracking how rising interest in critical minerals might benefit similar companies, it can be useful to scan other rare earth related opportunities through our 1 best rare earth metal stocks

After a sharp 7 day rebound but a much weaker 90 day stretch, the real tension around United States Antimony now sits in the valuation. Has the recent jump already priced in the story, or is there meaningful upside still on the table?

Most Popular Narrative: 48.9% Undervalued

At a last close of $6.67 versus a narrative fair value of $13.06, United States Antimony is framed as heavily discounted, with the story hinging on future growth and critical mineral positioning.

US Antimony is expanding its domestic processing capacity (for example, a sixfold increase at the Thompson Falls facility is expected by year-end) and increasing ore supply both from its own Montana/Alaska projects and multiple new international sources. This is expected to support higher production volumes and revenue through increased throughput and supply security.

Investors may want to understand what would need to occur for this expansion plan to support a higher fair value. The narrative references steep revenue compounding, rising margins, and a richer earnings multiple, and raises questions about how those elements align without relying on past profits.

Result: Fair Value of $13.06 (UNDERVALUED)

However, United States Antimony still faces real pressure from permitting delays on key projects, as well as the risk that expected government support or contracts do not fully materialize.

Another view on United States Antimony’s valuation

While the narrative fair value frames United States Antimony as undervalued, the simple P/S ratio tells a tougher story. The stock trades on a P/S of 25.2x versus 3.2x for the US Metals and Mining industry and a fair ratio of 5x. That is a wide gap. Is the growth story strong enough to justify it?

Next Steps

With sentiment mixed on United States Antimony, this is a moment to move quickly and review the underlying data yourself while the story is still forming. To see how risks and rewards line up in one place, take a closer look at the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond United States Antimony?

If United States Antimony has your attention, do not stop here. The next smart move is widening your watchlist with other clear, data backed opportunities.

• Spot potential value opportunities early by reviewing our 1 high quality undervalued stocks that align with solid fundamentals and disciplined pricing.
• Strengthen your focus on resilience by scanning the 83 resilient stocks with low risk scores that score well on financial risk measures.
• Get ahead of the crowd by checking the screener containing 21 high quality undiscovered gems before they attract wider market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.